Navigation Links
Kaj Blennow's research into M. Alzheimer recognized by the 2010 ECNP Neuropsychopharmacology Award
Date:9/7/2010

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Kaj Blennow as the recipient of the 2010 ECNP Neuropsychopharmacology Award in recognition of his original and influential contributions to Alzheimer's disease research. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in neuropsychopharmacology and closely related disciplines. The award is accompanied by a prize of 20,000.

Kaj Blennow, Professor in Clinical Neurochemistry at the University of Gothenburg and Senior Consultant at the Neurochemical Laboratory of Sahlgrenska University Hospital, Gothenburg, Sweden, is one of the world's leading researchers in Alzheimer's disease. His work has focused on the development of laboratory measures for clinical diagnosis and therapy monitoring in Alzheimer's disease, with significant implications for both drug development and patient care.

"In the field of brain disorders, the development of good biomarkers can enhance the possibilities for early diagnostics and the measurement of treatment effects" Blennow said at the 23rd ECNP Congress in Amsterdam, the Netherlands. "In the future this could enable clinicians to diagnose and treat Alzheimer's disease before the person experiences any symptoms."

The scope of Blennow's research is extensive. In Alzheimer's disease, as well as biomarkers, it has embraced genetic mechanisms, neurochemical pathogenesis and neurotransmitter disturbances. He has also extended his neurochemical innovations into other fields of neuropsychopharmacology, such as schizophrenia and depression. "We clearly need new drug targets and innovative leads for novel therapies," Blennow commented on the recent closure of neuroscience labs of major pharmaceutical companies in Europe. "The basis for modern drug development, which has a strong tradition in Europe for more than 50 years improving the quality of life of people struck by brain disorders, has to be kept alive."

By 2040 the incidence of Alzheimer's disease is expected to double in Western Europe and triple in Eastern Europe, as Europe's population ages. Speaking on behalf of the ECNP 2010 Award Jury, Guy Goodwin of the University of Oxford, United Kingdom, said, "Kaj Blennow's contributions to addressing this growing public health challenge have been outstanding. We are delighted to be able to present him with this award."


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
431-405-5734
European College of Neuropsychopharmacology
Source:Eurekalert

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. NC State researchers get to root of parasite genome
3. White Mountain Research Station to host climate change conference
4. Stevens awarded $1M for advanced biofuels research
5. Researchers find animal with ability to survive climate change
6. Researchers find an essential gene for forming ears of corn
7. Researchers note differences between people and animals on calorie restriction
8. Researcher working on destruction of chemical weapons
9. Researchers study acoustic communication in deep-sea fish
10. Researchers discover that growing up too fast may mean dying young in honey bees
11. The Rett Syndrome Research Trust launches operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/15/2016)... , March 15, 2016 Yissum ... , the technology-transfer company of the Hebrew University, announced ... of remote sensing technology of various human biological indicators. ... raising $2.0 million from private investors. ... based on the detection of electromagnetic emissions from sweat ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... ) - --> - Renvoi : image ... --> --> ... biométriques, fournit de nouveaux lecteurs d,empreintes digitales pour ... de DERMALOG sera utilisé pour produire des cartes ...
(Date:3/11/2016)... PUNE, India , March 11, 2016 ... to a new market research report "Image Recognition Market ... by Application (Marketing and Advertising), by Deployment Type (On-Premises ... Global Forecast To 2022", published by MarketsandMarkets, the global ... in 2015 to USD 29.98 Billion by 2020, at ...
Breaking Biology News(10 mins):
(Date:4/26/2016)... ... April 26, 2016 , ... ... Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, a genomics ... genomic technologies to market, was most recently Chief Commercial Officer of Pathway Genomics. ...
(Date:4/26/2016)... ... April 26, 2016 , ... ... systems, announces the latest technology innovation for its Volume Pattern Generator (VPG) line ... for production of advanced photomasks as well as a solution for mid volume ...
(Date:4/26/2016)... Boston, MA (PRWEB) , ... April 26, 2016 , ... ... Old Town Scottsdale and will offer attendees an opportunity to get the lowdown on ... , Over cocktails and appetizers, Dr. Jesse Hade, of Boston IVF - The ...
(Date:4/26/2016)... ... April 26, 2016 , ... Seattle based non-profit, The ... from 1Plus12 Corporation. The grant will be used to further the scientific research ... organization's website http://www.ivsci.org , In accounting the grant to the IVS, ...
Breaking Biology Technology: